British consumer goods company Reckitt Benckiser said on Sunday it agreed to buy privately-held Indian firm Paras Pharmaceuticals for 32.6 billion rupees ($726 million).
Like it on Facebook, Tweet it or share this topic on other bookmarking websites.
Reckitt Benckiser was advised by JP Morgan on the deal. Paras shareholders were advised by Morgan Stanley.
You do not have permissions to reply to this topic.